The Effects of Non-cryopreservation on Colony Formation of Committed Progenitor Cells of Bone Marrow
スポンサーリンク
概要
- 論文の詳細を見る
Bone marrow from five prospective candidates for autologous bone marrow transplantation was subjected to short-term non-cryopreservation at room temperature, and mononuclear cell counts, cellular viability, CFU-GM, CFU-E, BFU-E and CFU-Mk were tested on days 0, 1, 2, 3, 5 and 7 of preservation. On day 5, mononuclear cell counts were over 60% with cellular viability of approximately 80%, and the number of CFU-GM colonies remained at approximately 45% of the original value. Decreases in the numbers of CFU-E, BFU-E and CFU-Mk colonies, however, were more rapid. On the average, 50% preservation could be maintained for only 2 days. Thus the common belief that the CFU-GM assay is the most reliable parameter for qualifying the marrow inoculum in marrow transplantation can be challenged. We suggest that CFU-E, BFU-E and CFU-Mk are more sensitive with CFU-Mk being the most reliable. Judged from the decreasing numbers of CFU-Mk colonies, 48 hours appears to be the maximum period for non-cryopreservation of marrow under conditions of the study at room temperature. Vulnerabilities of marrow progenitors seem to differ from cell lineage to cell lineage, and this must be taken into careful consideration in pursuing marrow transplantation.
- 東海大学の論文
著者
-
Tajima Tomoo
Department Of Surgety Tokai University School Of Medicine
-
Tajima Tomoo
Department Of 2nd Surgery School Of Medicine Tokai University
-
Tajima T
Department Of General Surgery School Of Medicine Tokai University
関連論文
- Reconstruction of Sternal Defects with Autologous Bone Grafts and Myocutaneous Flap of the Latissimus Dorsi Muscle
- High-dose Chemotherapy Supported by Autologous Bone Marrow Transplantation in Solid Tumors
- Gastric Carcinoma with Lymphoid Stroma : Clinicopathological Studies of Four Cases
- Preliminary Study on the Optimal Dosage Schedule for Oral Tegafur/Uracil(UFT) Chemotherapy
- The in vivo development of human T cells from CD34^+ cells in the murine thymic environment
- Clinical and Histological Prognostic Factors in Axillary Node-Negative Breast Cancer: Univariate and Multivariate Analysis with Relation to 5-Year Recurrence
- Prognostic Parameters in Axillary Node Negative Breast Cancer
- Compassionate Use of Humanized Anti-HER2/neu Protein, Trastuzumab for Metastatic Breast Cancer in Japan
- Clinical Development of Trastuzumab in Breast Cancer
- Comparative Efficacy of Positron Emission Tomography and ultrasonography in Preoperative Evaluation of Axillary Lymph Node Metastases in Breast Cancer